Carthamus tinctorius flower extract prevents H2O 2-induced dysfunction and oxidative damage in osteoblastic MC3T3-E1 cells

Phytotherapy Research

Volumn 24, Issue 7, 2010, Pages 1037-1041

  Choi, Eun Mi ^a   Kim, Gun Hee ^a   Lee, Yong Soo ^a  

^a Duksung Women's University   (South Korea)

Author keywords

Carthamus tinctorius; Osteoblast; Oxidative stress

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; CARBONYL DERIVATIVE; COLLAGEN; HYDROGEN PEROXIDE; MALONALDEHYDE; OSTEOCLAST DIFFERENTIATION FACTOR; REACTIVE OXYGEN METABOLITE; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; SAFFLOWER EXTRACT;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CELL CULTURE; CELL DESTRUCTION; CELL FUNCTION; CELL PROTECTION; CELL VIABILITY; CIRCULATION; CONTROLLED STUDY; ENZYME ACTIVITY; FLOWER; LIPID PEROXIDATION; MOUSE; NONHUMAN; OSTEOBLAST; OXIDATION; OXIDATIVE STRESS; PROTEIN CARBONYLATION; SAFFLOWER;

ALKALINE PHOSPHATASE; ANIMALS; ANTIOXIDANTS; CALCIUM; CARTHAMUS TINCTORIUS; CELL LINE; COLLAGEN; FLOWERS; HYDROGEN PEROXIDE; LIPID PEROXIDATION; MICE; OSTEOBLASTS; OXIDATIVE STRESS; RANK LIGAND; REACTIVE OXYGEN SPECIES;

ASTERACEAE; CARTHAMUS TINCTORIUS;

EID: 77954500941     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3070     Document Type: Article

References (28)

1. Bai XC, Lu D, Bai J, Zheng H, Ke ZY, Li XM. 2004. Oxidative stress inhibits osteoblastic differentiation of bone cells by ERK and NF-κB. Biochem BiophysRes Co 314: 197-207.
2. Basu S, Michaelsson K, Olofsson H, Johansson S, Melhus H. 2001. Association between oxidative stress and bone mineral density. Biochem BiophysRes Co 288: 275-279.
3. Beckman KB, Ames BN. 1998. The free radical theory of aging matures. Physiolo Rev 78: 547-581. (Pubitemid 28182903)
4. Bi Y, Nielsen KL, Kilts TM, Yoon A, Karsdal MA, Wimer HF. 2005. Biglycan deficiency increases osteoclast differentiation and activity due to defective osteoblasts. Bone 38: 778-786.
5. Cheung AM, Feig DS, Kapral M, Diaz-Granados N, Dodin S. 2004. The Canadian Task Force on Preventive Health Care; Prevention of osteoporosis and osteoporotic fractures in postmenopausal women: Recommendation statement from the Canadian Task Force on Preventive Health Care. Can Med Assoc J 170: 1665-1667.
6. Davies MJ. 2003. Singlet oxygen-mediated damage to proteins and its consequences. Biochem BiophysRes Co 305: 761-770.
7. Domon S, Shimokawa H, Yamaguchi S, Kunimichi S. 2001. Temporal and spatial mRNA expression of bone sialoprotein and type I collagen during rodent tooth movement. Eur J Orthodont 23: 339-348.
8. Ermak G, Davies KJ. 2002. Calcium and oxidative stress: from cell signaling to cell death. Mol Immunol 38: 713-721.
9. Gallagher JC. 2008. Advances in bone biology and new treatments for bone loss. Maturitas 60: 65-69.
10. Garcia JJ, Reiter RJ, Pie J, Ortiz GG, Cabrera J, Sainz RM. 1999. Role of pinoline and melatonin in stabilizing hepatic microsomal membranes against oxidative stress. J Bioenerg Biomembr 31: 609-616.
11. Garrett IR, Boyce BF, Oreffo RO, Bonewald L, Poser J, Mundy GR. 1990. Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo. J Clin Invest 85: 632-639. (Pubitemid 20087462)
12. Hofbauer LC, Khosla S, Dunstan CR, Lacey DL, Boyle WJ, Riggs BL. 2000. The roles of osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Min Res 15: 2-12.
13. Hsu H, Lacey DL, Dunstan CR, Solovyev I, Colombero A, Timms E. 1999. Tumour necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Natl Acad Sci 96: 3540-3545.
14. Jung JH, Surh IO, Seung KR, Joo KM, Jeoung CS, Jung KH. 1999. Effects of Chrysanthemum indica L., Carthamus tinctorius L. and Propolis extract in endotoxin-induced thrombosis. The spring convention of the Pharmaceutical Society of Korea. Abstract PA3-10.
15. Kültz D. 2005. Molecular and evolutionary basis of the cellular stress response. Annu Rev Physiol 67: 1-33.
16. Key Jr LL, Wolf WC, Gundberg CM, Ries WL. 1994. Superoxide and bone resorption. Bone 15: 431-436.
17. Kim MN, Le Scao-Bogaert F, Paris M. 1992. Flavonoids from Carthamus tinctorius flowers. Planta Medica 58: 285-289.
18. Lean JM, Jagger CJ, Kirstein B, Fuller K, Chambers TJ. 2005. Hydrogen peroxide is essential for estrogen-deficiency bone loss and osteoclast formation. Endocrinology 146: 728-735.
19. Manolagas SC, Jilka RL. 1995. Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. New Eng J Med 322: 305-311.
20. Masao H, Huang XL, Che QM, Kawata Y, Tezuka Y, Kikuchi T, Namba T. 1992. 6-Hydroxykaempferol and its glycosides from Carthamus tinctorius petals. Phytochemistry 31: 4001-4004
21. Mayo JC, Tan DX, Sainz RM, Natarajan M, Lopez-Burillo S, Reiter RJ. 2003. Protection against oxidative protein damage induced by metal-catalyzed reaction or alkylperoxyl radicals: comparative effects of melatonin and other antioxidants. Biochimica et Biophysica Acta 1620: 139-150.
22. Namba T. 1993. The encyclopedia of Wakan-Yaku (traditional Sino-Japanese medicines) with color pictures. Vol. 11. Hoikusha, Tokyo; 100-101.
23. Narisawa S, Frohlander N, Millan JL. 1997. Inactivation of two mouse alkaline phosphatase genes and establishment of a model of infantile hypophosphatasia. Dev Dynam 208: 432-446.
24. Ohba M, Shibanuma M, Kuroki T, Nose K. 1994. Production of hydrogen peroxide by transforming growth factor-beta 1 and its involvement in induction of egr-1 in mouse osteoblastic cells. J Cell Biol 126: 1079-1088.
25. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R. 1997. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89: 309-319.
26. Tullberg-Reinert H, Jundt G. 1999. In situ measurement of collagen synthesis by human bone cells with a Sirius Red-based colorimetric microassay: effects of transforming growth factor β2 and ascorbic acid 2-phosphate. Histochemistry and Cell Biology 112: 271-276.
27. 2 toxicity in human neuroblastoma SK-N-SH cells. Mol Pharmacol 70: 395-404.
28. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki SI. 1998. Osteoclast differentiation factor is a ligand for osteoprotegerin/ osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANK L. Proc Natl Acad Sci 95: 3597-3602.